Sign In
BIVV.US
id: 663, Created by Stan Vick, Scout

Bioverativ (BIVV) $84M Shareholder Settlement

How it works?
  1. Company agreed to settle with investors to avoid further litigation
  2. We prepare documents and claim payout for you
Delaware court of Chancery
Court
2020-1061
Case number
24 May 2017
Class period Start
08 Mar 2018
Class period End
This settlement of $84 million resolves claims over the acquisition of Bioverativ by Sanofi, whereby $BIVV stockholders received $105 in cash for each.
Alleged Offence
Misleading Statements, 
Financial Misrepresentation, 
Failure to Disclose, 
Breach of Fiduciary duty, 
Omissions
Suspected Party
Directors, 
Management, 
Shareholder, 
Investment Bank, 
Service Provider
Security Type
Stocks
Trade Direction
Long
Filing date
07 March 2018
Plaintiffs
Stewart N. Goldstein, M.D.
Attorneys
Prickett, Jones & Elliott, P.A., Cooch & Taylor P.A., Robbins Geller Rudman & Dowd LLP, Johnson Fistel LLP
Defendants
John G. Cox, Anna Protopapas, Brian S. Posner, Louis J. Paglia, Geno J. Germano, John T. Greene, Andrea DiFabio, Alexander J. Denner
Judge
Judge Phillips
Administrator
Gilardi & Co LLC
Settlement agreement date
2023-03-12
Trades matching type
FIFO
+$84,000,000
Total Settlement Amount
Created by Stan Vick, Scout

Bioverativ Inc

Bioverativ Inc., a biotechnology company, focuses on the research, discovery, development, and commercialization of therapies for the treatment of hemophilia and other blood disorders in the United...

    Ticker
    BIVV.US
    ISIN
    US09075E1001
    CIK
    1681689
    Sector
    Other
    Industry
    Other
    Country
    USA
    Address
    225 Second Avenue 02451,Waltham,USA